For the first time, the US Food and Drug Administration (FDA) has approved two drugs intended to help behavioural problems in pets. Clomipramine can now be used to treat canines suffering from separation anxiety -- unnatural behaviour when the owner leaves it alone. The second drug, selegiline, can be used to treat cognitive dysfunction syndrome, a common age-related dementia. Both the drugs are also used to treat humans. Clomipramine is an antidepressant while selegiline is usually given to patients of Parkinson's disease.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.